|
1
|
Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
|
Hepatology
|
2006
|
3.19
|
|
2
|
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
|
Hepatology
|
2009
|
2.45
|
|
3
|
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
PLoS Genet
|
2013
|
2.39
|
|
4
|
Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.
|
Eur J Gastroenterol Hepatol
|
2005
|
1.94
|
|
5
|
Antiviral action of ribavirin in chronic hepatitis C.
|
Gastroenterology
|
2004
|
1.92
|
|
6
|
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.
|
Clin Chem
|
2007
|
1.84
|
|
7
|
Evaluation of in silico splice tools for decision-making in molecular diagnosis.
|
Hum Mutat
|
2008
|
1.78
|
|
8
|
Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C.
|
Hepatology
|
2009
|
1.55
|
|
9
|
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
|
BMC Gastroenterol
|
2007
|
1.49
|
|
10
|
Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohort.
|
Gastroenterol Clin Biol
|
2006
|
1.42
|
|
11
|
Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.
|
J Clin Psychiatry
|
2005
|
1.41
|
|
12
|
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
|
J Natl Cancer Inst
|
2010
|
1.41
|
|
13
|
[Steasis and hepatitis C].
|
Gastroenterol Clin Biol
|
2003
|
1.41
|
|
14
|
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
|
J Hepatol
|
2006
|
1.25
|
|
15
|
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.17
|
|
16
|
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
|
PLoS Biol
|
2011
|
1.12
|
|
17
|
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.
|
Oncologist
|
2014
|
1.09
|
|
18
|
Update on ultrasound imaging of liver fibrosis.
|
J Hepatol
|
2013
|
1.07
|
|
19
|
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study.
|
J Hepatol
|
2010
|
1.01
|
|
20
|
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
|
Am J Gastroenterol
|
2008
|
0.94
|
|
21
|
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
|
Carcinogenesis
|
2004
|
0.92
|
|
22
|
Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis.
|
Eur Radiol
|
2014
|
0.92
|
|
23
|
Psychosocial factors associated with perceived disease severity in patients with chronic hepatitis C: relationship with information sources and attentional coping styles.
|
Psychosomatics
|
2005
|
0.88
|
|
24
|
FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.
|
Hepatology
|
2006
|
0.88
|
|
25
|
Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines.
|
J Leukoc Biol
|
2007
|
0.86
|
|
26
|
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel.
|
Breast Cancer Res Treat
|
2010
|
0.86
|
|
27
|
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.
|
Antivir Ther
|
2009
|
0.83
|
|
28
|
[Hepatitis C virus screening in drug users in an addiction out-patient unit].
|
Gastroenterol Clin Biol
|
2002
|
0.80
|
|
29
|
Exploring the link between MORF4L1 and risk of breast cancer.
|
Breast Cancer Res
|
2011
|
0.79
|
|
30
|
Liver stiffness and hepatocellular carcinoma: liaisons dangereuses?
|
Hepatology
|
2009
|
0.78
|
|
31
|
Assessing liver disease in HIV-HCV coinfected patients.
|
Curr Opin HIV AIDS
|
2015
|
0.78
|
|
32
|
Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography.
|
Eur Radiol
|
2014
|
0.78
|
|
33
|
HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system.
|
Gastroenterol Clin Biol
|
2007
|
0.77
|
|
34
|
A missense variant within BRCA1 exon 23 causing exon skipping.
|
Cancer Genet Cytogenet
|
2010
|
0.77
|
|
35
|
Acoustic radiation force impulse imaging: a new technology for the noninvasive assessment of liver fibrosis?
|
J Gastrointestin Liver Dis
|
2009
|
0.75
|
|
36
|
Diagnosing cirrhosis non-invasively: sense the stiffness but don't forget the nodules!
|
J Hepatol
|
2010
|
0.75
|
|
37
|
Biomarkers in liver disease: emerging methods and potential applications.
|
Int J Hepatol
|
2012
|
0.75
|
|
38
|
[Brief intervention about alcohol use].
|
Presse Med
|
2009
|
0.75
|
|
39
|
[Liver biopsy in management of chronic liver diseases: "EASL monothematic conference highlights"].
|
Gastroenterol Clin Biol
|
2006
|
0.75
|
|
40
|
Intratumoral gas in hepatocellular carcinoma following transarterial chemoembolization: associated factors and clinical impact.
|
J Vasc Interv Radiol
|
2013
|
0.75
|
|
41
|
[Managing comorbidities in hepatology: toward a more holistic medicine].
|
Presse Med
|
2008
|
0.75
|